Dorothy Markowitz
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
- Oncology 7
- Cancer Cells and Metastasis 3
- Peptidase Inhibition and Analysis 1
- Cytokine Signaling Pathways and Interactions 1
-
- Immune cells in cancer 5
- Immunotherapy and Immune Responses 3
- Co-authors
- Rong Xiang (8 shared papers)Ralph A. Reisfeld (7 shared papers)Yunping Luo (6 shared papers)Debbie Liao (2 shared papers)He Zhou (6 shared papers)Tsung‐Hsien Chuang (2 shared papers)Jian Yang (1 shared paper)Cong Chen (1 shared paper)
- Journals
- Stem Cells (1 paper)British Journal of Cancer (1 paper)Vaccine (1 paper)Cancer Immunology Immunotherapy (1 paper)Oncogene (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Dorothy Markowitz
9 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 76
- Oncology 643
- Cancer Research 251
- Immunology 336
- Biotechnology 82
- Molecular Biology 495
Countries citing papers authored by Dorothy Markowitz
This map shows the geographic impact of Dorothy Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothy Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothy Markowitz more than expected).
Fields of papers citing papers by Dorothy Markowitz
This network shows the impact of papers produced by Dorothy Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothy Markowitz. The network helps show where Dorothy Markowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Dorothy Markowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 353 | |
| 2 | 2012 | 242 | |
| 3 | 2011 | 155 | |
| 4 | 2007 | 77 | |
| 5 | 2009 | 77 | |
| 6 | 2006 | 75 | |
| 7 | Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27. | 1992 | 28 |
| 8 | 2006 | 15 | |
| 9 | Targeting tumor-associated macrophages: A novel strategy against breast cancer. | 2006 | 1 |
About Dorothy Markowitz
Dorothy Markowitz is a scholar working on Oncology, Immunology, Molecular Biology, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Cancer Research and Treatments (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Cells and Metastasis (3 papers), Peptidase Inhibition and Analysis (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Oncology (643 citations), Cancer Research (251 citations), Immunology (336 citations), Biotechnology (82 citations) and Molecular Biology (495 citations). Dorothy Markowitz has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Rong Xiang, Ralph A. Reisfeld, Yunping Luo, Debbie Liao, He Zhou, Tsung‐Hsien Chuang, Jian Yang, Cong Chen, R. Reisfeld and Daiqing Liao. Their work appears in journals such as Stem Cells, British Journal of Cancer, Vaccine, Cancer Immunology Immunotherapy and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.